iopromide has been researched along with Neointima in 3 studies
iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.
Neointima: The new and thickened layer of scar tissue that forms on a PROSTHESIS, or as a result of vessel injury especially following ANGIOPLASTY or stent placement.
Excerpt | Relevance | Reference |
---|---|---|
"Paclitaxel delivery to porcine ilio-femorals using PCB followed by BMS implantation effectively decreased neointimal proliferation." | 3.77 | Paclitaxel-iopromide coated balloon followed by "bail-out" bare metal stent in porcine iliofemoral arteries: first report on biological effects in peripheral circulation. ( Aboodi, MS; Conditt, GB; Granada, JF; Gray, WA; Kaluza, GL; McGregor, JC; Milewski, K; Stenoien, M; Tellez, A; Thim, T; Virmani, R; Yi, GH, 2011) |
"In histology, percentage area of stenosis (BMS+PCB=29." | 1.39 | Stent healing response following delivery of paclitaxel via durable polymeric matrix versus iopromide-based balloon coating in the familial hypercholesterolaemic swine model of coronary injury. ( Afari, M; Buszman, PP; Cheng, Y; Conditt, GB; Granada, JF; Kaluza, GL; McGregor, JC; Milewski, K; Stenoien, M; Tellez, A, 2013) |
"Paclitaxel tissue uptake was assessed in 20 iliofemoral arteries of a domestic swine." | 1.39 | Tissue uptake, distribution, and healing response after delivery of paclitaxel via second-generation iopromide-based balloon coating: a comparison with the first-generation technology in the iliofemoral porcine model. ( Afari, ME; Buszman, PP; Conditt, GB; Granada, JF; Kaluza, GL; McGregor, JC; Peppas, A; Rousselle, SD; Stenoien, M; Tellez, A, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buszman, PP | 2 |
Tellez, A | 3 |
Afari, M | 1 |
Cheng, Y | 1 |
Conditt, GB | 3 |
McGregor, JC | 3 |
Milewski, K | 2 |
Stenoien, M | 3 |
Kaluza, GL | 3 |
Granada, JF | 3 |
Afari, ME | 1 |
Peppas, A | 1 |
Rousselle, SD | 1 |
Aboodi, MS | 1 |
Yi, GH | 1 |
Thim, T | 1 |
Gray, WA | 1 |
Virmani, R | 1 |
3 other studies available for iopromide and Neointima
Article | Year |
---|---|
Stent healing response following delivery of paclitaxel via durable polymeric matrix versus iopromide-based balloon coating in the familial hypercholesterolaemic swine model of coronary injury.
Topics: Angioplasty, Balloon, Coronary; Animals; Cardiovascular Agents; Constriction, Pathologic; Coronary A | 2013 |
Tissue uptake, distribution, and healing response after delivery of paclitaxel via second-generation iopromide-based balloon coating: a comparison with the first-generation technology in the iliofemoral porcine model.
Topics: Angioplasty, Balloon; Animals; Arterial Occlusive Diseases; Cardiovascular Agents; Cell Proliferatio | 2013 |
Paclitaxel-iopromide coated balloon followed by "bail-out" bare metal stent in porcine iliofemoral arteries: first report on biological effects in peripheral circulation.
Topics: Angioplasty, Balloon; Animals; Blood Circulation; Cell Proliferation; Dose-Response Relationship, Dr | 2011 |